INTRODUCTION 2. MATERIALS AND METHODS
Glucagon-like peptide-1(7-36)amide is a posttranslational processing product of proglucagon in the mammalian intestine [l-3] . Since it is released in response to oral glucose loads and has been shown to be a powerful stimulator of the glucose-induced insulin release [2,4-61, it was concluded to represent an important incretin candidate.
Receptors for GLP-1(7-36)amide are present in different tissues. Previously, we identified and characterized high-affinity receptors for GLP-1(7-36)amide in a rat insulinoma-derived cell line (RINmSF) [7, 8] which are coupled to the adenylate cyclase system [9] . Uttenthal and Blizquez demonstrated the presence of GLP-1(7-36)amide receptors on isolated rat gastric glands [lo] . Binding of GLP-1(7-36)amide to gastric glands resulted in an increase of CAMP suggesting that like in RINmSF cells the receptor for GLP-1(7-36)amide is linked to the adenylate cyclase. Several studies showed that in brain the thalamus, hypothalamus, pituitary gland and medulla oblongata are rich in GLP-1(7-36)amide binding sites [l 1,121. Recently, it has been shown that GLP-1(7-36)amide binds specifically to rat lung membranes and that this binding is pH dependent [12] . The present study was performed to further characterize GLP-1(7-36)amide receptors on rat lung membranes. Brielly. male albmo \Vistar rats (200-220 g body weight) were kllled by decapltatlon, the lungs were removed and homogenized m IO mhl trls(hqdroxymethqI)aminomethane hydrochloride (Trl\-HCI).
30 mhl NaCl, 1 mhl dlthlothreltol, 5 pM phenylmethylsulfonqltluorlde (PhlSF). pH 7.5, with an Ultra-Turrax followed by a further homogemratlon using a glasvglass homogenizer.
The homogenate was layered oker a 41'% (a, v) sucrose solution and centrifuged for 60 mln at 4°C at 95000 x ,g. The band at the Interface of the layers represented the membrane5 and \\a\ collected, diluted and centrifuged for 30 mm at 4°C at 40000 \ g. GLP-1(7-36)amide (approx. 40000 cpm) in modtfied KRB at 37°C for 30 min m the presence of the indicated substances.
After centrifugatton for 5 min at 4°C at 11500 x g the pellet was counted in a y-counter (Hydragamma 16, Innotron, Oxford, UK). Nonspecific binding was defined as binding m the presence of 1 pmol/l GLP-1(7-36)amide and was subtracted in every case from the totalbinding value.
RESULTS

Binding
of 1251-labelled GLP-1(7-36)amide to rat lung membranes
(1 mg/ml protein) was temperaturedependent.
Binding was rapid at 37°C and markedly reduced at 10°C (Fig. 1) . Binding was dependent on membrane protein concentration over the protein concentration range of lo-lOOpg/sample (Fig. 1) . Binding of 1251-labelled GLP-1(7-36)amide was inhibited in a concentration-dependent manner by GLP-1(7-36)amide consistent with the presence of a single class of binding sites with a dissociation constant (&) of 1.67 f 0.29 nmol/l (Fig. 2) . Binding of 1251-labelled GLP-1(7-36)amide was also inhibited in a concentration-dependent manner by GLP-1(7-36)amide but the binding affinity was ap- proximately 260-fold less than that of the truncated peptide. The Kd was 448 -+ 93 nmol/l (Fig. 2) . VIP and PHI were also able to displace *2SI-labelled GLP-1(7-36)amide concentration-dependently with a Kd of 4.31 f 0.8 and 7.93 + 4.79 nmol/l, respectively (Fig. 2) .
Binding of tracer was weakly, but reproducibly, inhibited by glucagon and GLP-2. Thus, at a concentration of 1 pmol/l, glucagon and GLP-2 inhibited binding of tracer by 45% (Fig. 2) . Binding of label was not significantly inhibited by oxyntomodulin and GRPP. Table I Effect of GDP-p-S and GTP-y-S on binding of 'z51-labelled GLP-1(7-36)amtde to rat lung membranes (means f SE; n = 6) 0. I pmol/l 1 .O pmol/l 10 pmol/l 100 pmol/l -Control 100 GDP-P-S 62.0 k 1.73 24.17 k 0.83 11.33 k 0.88 9.0 t 0.58 GTP-7-S 64.83 f 5.30 15.33 f 1.12 11.50 f 0.34
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In further experiments lung membranes (1 mg/ml protein) were incubated for 30 min at 37°C with lz51-labelled GLP-1(7-36)amide in the absence or presence of a range of concentrations of GTP-T-S and GDP-P-S. As shown in Table I , binding of tracer was inhibited in a concentration-dependent manner by the nucleotides.
DISCUSSION
Our results demonstrate the presence of high affinity receptors for GLP-1(7-36)amide on isolated rat lung membranes.
Consistent with the data of Kanse et al. [12] , we found that GLP-1(1-36)amide competes with '251-labelled GLP-1(7-36)amide much less strongly than GLP-1(7-36)amide.
In contrast to their results, we found that VIP and PHI were more potent in displacing '251-labelled GLP-1(7-36)amide than other proglucagon-derived peptides, except GLP-1(7-36)amide itself. The order of potency was GLP-1(7-36)amide > VIP > PHI > GLP-1(1-36)amide > glucagon and GLP-2. Previously we identified and characterized receptors for GLP-1(7-36)amide on rat insulinoma-derived RINmSF cells [7, 8] . Our results show that the binding affinity of GLP-1(7-36)amide on rat lung receptors is 10 times less compared to the receptors on RINm5F cells (1.67 + 0.29 nmol/l vs 0.204 k 0.08 nmol/l). While VIP and PHI did not bind to GLP-1(7-36)amide receptors on insulinoma cells both peptides were able to displace "I-labelled GLP-1(7-36)amide with a Kd which was 2.5 and 4.7 times, respectively, less than that of GLP-1(7-36)amide.
Previously, we demonstrated that GLP-1(7-36)amide receptors on RINm5F cells are coupled to the adenylate cyclase system [9] . We now show that binding of "' I-labelled GLP-1(7-36)amide to lung membranes is decreased in the presence of guanine nucleotides suggesting that these receptors are also linked to adenylate cyclase system.
The presence of GLP-1(7-36)amide receptors on rat lung membranes indicates that the peptide may not only act, as has been suggested, as an incretin [2,4-61 but ma; have additional, so far undefined, functions. Studies are currently underway to obtain information on the possible functional relevance of these findings.
Interestingly, there are several reports of the presence of GLP-1(7-36)amide binding sites in the brainstem [I 1,15-191 . These findings along with ours infer that GLP-1(7-36)amide may have a role in peripheral and central regulation of pulmonary function.
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